Podcast Episodes

Back to Search
Iovance wins with Amtagvi and the ADC train chugs on
Iovance wins with Amtagvi and the ADC train chugs on

This week Lori, Greg and Tyler discuss the Accelerated Approval of Amtagvi, the first one-time cell therapy for solid tumors and the first TIL therap…

2 years, 4 months ago

Short Long
View Episode
Eyes on the prize: Novo buys Catalent
Eyes on the prize: Novo buys Catalent

This week, Greg, Heather and Tyler discuss reaction to Novo Nordisk's purchase of Catalent and speculate on what that means for existing manufacturin…

2 years, 4 months ago

Short Long
View Episode
Balancing act: Patient access and innovation
Balancing act: Patient access and innovation

This week Lori, Greg and Tyler discuss drug pricing reforms. CMS sent offers to manufacturers of the 10 drugs that have been selected for Medicare pr…

2 years, 5 months ago

Short Long
View Episode
Keep calm and CAR-T on?
Keep calm and CAR-T on?

Almost 30,000 patients have now been treated with CAR-T cell therapies since it was the first approval in 2017. In November 2023, the FDA launched a …

2 years, 5 months ago

Short Long
View Episode
What can biopharma expect from the job market?
What can biopharma expect from the job market?

Following a challenging year of layoffs and limited funding, Chantal Dresner, VP of Marketing at BioSpace, discusses the findings of our most recent …

2 years, 5 months ago

Short Long
View Episode
Grab an umbrella, it's raining ⁠IPOs⁠!
Grab an umbrella, it's raining ⁠IPOs⁠!

The first surge of IPO activity this year sees Alto Neuroscience, ArriVent Biopharma, CG Oncology, Kyverna Therapeutics and Metagenomi making announc…

2 years, 5 months ago

Short Long
View Episode
Optimistic, but for how long? Our big takeaways from #JPM2024
Optimistic, but for how long? Our big takeaways from #JPM2024

The team comes together to discuss the dominant themes of what was an incredibly busy week of events in San Francisco.

There was an air of hope and …

2 years, 5 months ago

Short Long
View Episode
On the ground at #JPM2024 - Day 3 highlights
On the ground at #JPM2024 - Day 3 highlights

We're still in San Francisco covering the JP Morgan Healthcare Conference and Biotech Showcase, bringing you key themes from day three: disruptive AI…

2 years, 5 months ago

Short Long
View Episode
On the ground at #JPM2024 - Day 2 highlights
On the ground at #JPM2024 - Day 2 highlights

Once again we're recording from San Francisco covering the JP Morgan Healthcare Conference and Biotech Showcase, bringing you key themes from day two…

2 years, 6 months ago

Short Long
View Episode
On the ground at #JPM2024 - Day 1 highlights
On the ground at #JPM2024 - Day 1 highlights

Hello from San Francisco! BioSpace is reporting from #JPM2024 bringing you key takeaways and highlights from day one.

Join Lori, Greg and Tyler as th…

2 years, 6 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us